Santhera’s Phase IIb vamorolone for DMD has experts cautious on trustworthiness of BMI-Z score safety data
In a DMD population where there is a risk of decline in function, any improvement is meaningful. Credit: Shutterstock + hafakot.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more